Dual glucose-hydroxybutyrate analytical sensors

• US 6,984,307 B2
• Filed: 10/03/2002
• Issued: 01/10/2006
• Est. Priority Date: 10/05/2001
• Status: Expired due to Fees

• Current Assignee: Stephen Eliot Zweig
• Original Assignee: Stephen Eliot Zweig
• Inventors: Zweig, Stephen Eliot
• Primary Examiner(s): NOGUEROLA, ALEXANDER STEPHAN
• Application Number:
  US10/264,206
• Publication Number:
  US 20030068666A1
• Time in Patent Office: 1,195 Days
• Field of Search: 20440301-40312, 204/403.14, 204/403.15, 436/14, 436/95, 436/128, 436/164, 422/56, 205/777.5
• US Class Current: 205/777.5
• CPC Class Codes: C12Q 1/005 involving specific analytes or enzymes including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence
• CPC Class Codes: C12Q 1/006 for glucose
• CPC Class Codes: G01N 33/523 the element being adapted for a specific analyte
• CPC Class Codes: G01N 33/66 involving blood sugars, e.g. galactose

Abstract

Diagnostic dry reagent tests capable of reacting with a single drop of whole blood and reporting both glucose and beta-hydroxybutyrate levels are taught. Such dry reagent tests may employ electrochemical detection methodologies, optical detection methodologies, or both methodologies. These tests help facilitate the early detection of the onset of ketoacidosis in diabetes.

Claims

1. A dry reagent diagnostic device for the simultaneous enzymatic analysis of two different analytes in a single application of a single 1–

20 ul sample of whole blood, wherein

the fast analyte is determined by a fast reaction zone, and a second reaction zone, physically separated from the first reaction zone, determines the second analyte;

a fluid bridge formed by the applied sample connects the two reaction zones;

said first reaction zone and second reaction zone having reaction materials and geometry;

selected to allow simultaneous rehydration and activation of both zones by a single unseparated whole blood drop;

said reaction zone materials and geometry being selected so as to return detectable analyte signals in the presence of whole blood;

said reaction zone materials and geometry being selected as to generate a detectable sample application signal upon initial contact with whole blood;

said detectable sample application signal being capable of triggering an automated reaction zone reader which is capable of performing subsequent test timing in an automated manner;

and at least one of the reaction zones produces a detectable change in an optical signal.

2. The device of claim 1, in which the analytes are glucose and beta-hydroxybutyrate.

3. The device of claim 2, in which one reaction zone is an electrochemical reaction zone, and the reaction detected is an electrochemical reaction, wherein said device has at least one working electrode for said electrochemical reaction zone, and at least one reference electrode.

4. The device of claim 3, in which said at least one electrode contains carbon particles.

5. The device of claim 3, in which said electrochemical reaction zone detects glucose, said electrochemical reaction zone contains a glucose sensing electrode, and said glucose electrode contains or is associated with a glucose oxidase enzyme and an electron transfer mediator.

6. The device of claim 3, in which said electrochemical reaction zone detects glucose, said electrochemical reaction zone contains a glucose sensing electrode, and said glucose electrode contains or is associated with glucose dehydrogenase enzyme and an electron transfer mediator.

7. The device of claim 3, in which said electrochemical reaction zone detects beta-hydrozybutyrate, said electrochemical reaction zone contains a beta-hydroxybutyrate sensing electrode, and said beta-hydroxybutyrate electrode contains or is associated with beta-hydroxybutyrate dehydrogenase enzyme and an electron transfer mediator.

8. The device of claim 3, in which one or more layers of a microporus, microparticle and binder composition, which allows plasma to pass but blocks red cells, cover said at least one working electrode for said electrochemical reaction zone.

9. The device of claim 8, in which one or more layers of the microporus, microparticle and binder composition are rendered microporous through a freeze-drying step.

10. The device of claim 8, in which the microporous microparticle composition is composed of spherical particles with a diameter between 0.1 and 50 microns.

11. The device of claim 2, in which said optical signal is selected from group consisting of colorimetric, fluorescent, or luminescent signals.

12. The device of claim 11, in which said analyte determined by said reaction zone producing a detectable change in an optical signal is glucose and said reaction zone of the device contains or is associated with a glucose oxidase enzyme, peroxidase, and a hydrogen peroxide sensitive optical indicator dye.

13. The device of claim 11, in which said analyte determined by said reaction zone producing a detectable change in an optical signal is glucose and said reaction zone of the device contains or is associated with a glucose dehydrogenase enzyme, NAD, diaphorase, and a NADH sensitive optical indicator dye.

14. The device of claim 11, in which said analyte determined by said reaction zone producing a detectable change in an optical signal is beta-hydroxybutyrate and said reaction zone of the device contains or is associated with a beta-hydroxybutyrate dehydrogenase enzyme, NAD, diaphorase, and a NADH sensitive optical indicator dye.

15. The device of claim 1, in which a chemical sample application signal detection means is incorporated into at least one of the reaction zones, and in which the chemical sample application signal detection means changes its colorimetric, fluorescent, or luminescent state upon contact with the liquid sample.

16. The device of claim 15, in which an increase in reflectance on at least one wavelength of the chemical sample application signal detection means is used to trigger the start of an automated meter system that monitors the reaction optically.

17. The device of claim 1, in which the first analyte produces an electrochemical signal, and in which the second analyte produces a detectible change in an optical signal.

18. The device of claim 17, in which the device contains conducting electrodes to transmit the electrochemical signal, and an optical wave guide to transmit the optical signal.

19. The device of claim 18, in which the optical wave guide is a single optical fiber.

20. A method for determining the concentration of two or more analytes in a single sample of whole blood with a volume under 20 ul, comprising the steps of;

applying said blood sample to a dry reagent diagnostic device in a single application, said dry reagent diagnostic device containing at least two reaction zones;

wherein a first analyte in said sample is determined by a first reaction zone, and a second reaction zone, physically separated from the first reaction zone, determines a second analyte in said sample;

forming a fluid bridge with the applied blood sample to connect;

all reaction zones on said device;

said first reaction zone and second reaction zone having reaction zone materials and geometry; and

selected to allow simultaneous rehydration and activation of all zones by a single unseparated whole blood drop;

said reaction zone materials and geometry being selected as to return detectable analyte signals in the presence of whole blood;

and determining the concentration of at least one of said analytes from at least one of said reaction zones by a detectable change in an optical signal.

21. The method of claim 20, in which at least one analyte produces an electrochemical signal, and in which at least one analyte produces a detectible change in an optical signal.

22. The method of claim 20, in which the dry reagent diagnostic device contains conducting electrodes to transmit an analyte produced change in an electrochemical signal, and an optical wave guide to transmit an analyte produced change in an optical signal.

23. The method of claim 20, in which said reaction zone materials and geometry are selected as to generate a detectable sample application signal upon initial contact with whole blood;

and

said detectable sample application signal being capable of triggering an automated reaction zone reader which is capable of performing subsequent test timing in an automated manner.